Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Non-Hodgkin 70 Lymphoma, Large B-Cell, Diffuse 67 Lymphoma 66 Lymphoma, Follicular 59 Leukemia, Lymphocytic, Chronic, B-Cell 58 Lymphoma, B-Cell, Marginal Zone 30 Burkitt Lymphoma 30 Waldenstrom Macroglobulinemia 24 Lymphoma, Mantle-Cell 24 Lymphoma, B-Cell 24 Precursor Cell Lymphoblastic Leukemia-Lymphoma 22 Leukemia 19 Recurrence 17 Hodgkin Disease 12 Neoplasms 10 Lymphoma, Large-Cell, Immunoblastic 10 Multiple Myeloma 8 Leukemia, Prolymphocytic 8 Leukemia, Myeloid, Acute 8 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 7 Myelodysplastic Syndromes 7 Mycosis Fungoides 6 Lymphoma, T-Cell, Cutaneous 6 Leukemia, Hairy Cell 6 Sezary Syndrome 5 Neoplasms, Plasma Cell 5 Lymphoma, Large-Cell, Anaplastic 5 Lymphoma, Extranodal NK-T-Cell 5 Intraocular Lymphoma 5 Dendritic Cell Sarcoma, Interdigitating 5

Interventions

obinutuzumab 1 ioflupane 1 idelalisib 1 daratumumab 1 alovudine 1 Vindesine 1 Vincristine 1 Rituximab 1 Prednisone 1 Positron Emission Tomography Computed Tomography 1 Mitomycin 1 Magnetic Resonance Spectroscopy 1 Lenalidomide 1 Ga(III)-DOTATOC 1 Doxorubicin 1 Dexamethasone 1 Cyclophosphamide 1 Bleomycin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Disease × Rituximab × Clear all

NCT01659099 2018-03-07

GAINED

The Lymphoma Academic Research Organisation

Phase 3 Terminated

Disease, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡